GIT1 loss of function causes a recognizable syndromic neurodevelopmental disorder
Clicks: 2
ID: 318936
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
2 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #375 of 378 articles by views in Brain research
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 378 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract The G-protein-coupled receptor kinase-interacting protein 1, GIT1, is a multifunctional scaffold protein that plays key roles in the regulation of actin cytoskeletal dynamics, focal adhesion assembly, membrane trafficking, and intracellular signaling. In mice, loss of Git1 function causes a microcephaly-like phenotype characterized by a smaller brain due to reduced neuronal cell size, accompanied by behavioral deficits, altered gait, and impairment in motor coordination, learning and memory. To date, variants in GIT1 have not been definitely linked to human disease. By applying a combined genomic approach based on linkage analysis and exome sequencing, we provide evidence that biallelic GIT1 variants affecting transcript processing or causing premature termination underlie a syndromic neurodevelopmental disorder. Nine affected individuals from three families were identified to share a clinically homogeneous syndromic phenotype with major features including microcephaly, brain MRI anomalies, developmental delay/intellectual disability, a recognizable facial gestalt, and intrauterine growth restriction with postnatal growth failure. We used complementary in vitro and in vivo approaches to validate this causal relationship. Cell-based functional analyses using patient-derived fibroblasts confirmed the inactivating behavior of the disease-associated variants and demonstrated that loss of GIT1 function disrupts actin cytoskeleton dynamics, leading to defective cell spreading and flawed formation of focal adhesions as a result of reduced RAC1 activation. A zebrafish git1 knockdown model recapitulated the clinical phenotype observed in affected patients and further validated the loss-of-function effect of the identified variants. Collectively, our findings establish an essential role for GIT1 in development and cognitive function.
| Reference Key |
openalex_W7166031541
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Pinella Failla, Valentina Muto, Antonella Lauri, Lucia Saccuzzo, Alessia Arena, Giulia Fasano, Anne-Marie Guerrot, François Lecoquierre, Andrea Ciolfi, Cecilia Mancini, Erika Zara, Viviana Cordeddu, Marialetizia Motta, Maurizio Elia, Donatella Greco, Emanuela Avola, Teresa Mattina, Angela Spalletta, Pietro Schinocca, Michele Salemi, Maria Grazia Salluzzo, Ornella Galesi, Emmanuel de Billy, Stefania Petrini, Simona Coppola, Manuela Priolo, Enrico Bertini, Francesca Clementina Radio, Corrado Romano, Marco Fichera, Marco Tartaglia |
| Journal | Brain research |
| Year | 2026 |
| DOI |
10.1093/brain/awag223
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.